2,2,2-trifluoro-N-(2-methoxyphenethyl)acetamide | 304458-32-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 2,2,2-trifluoro-N-(2-methoxyphenethyl)acetamide
• 英文别名: N-(2-methoxyphenethyl)-2,2,2-trifluoroacetamide；2,2,2-trifluoro-N-[2-(2-methoxyphenyl)ethyl]acetamide
• CAS: 304458-32-0
• 化学式: C₁₁H₁₂F₃NO₂
• 分子量: 247.217
• InChiKey: SSGBTJFYDLXTKE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  5

安全信息

• 危险等级：
  IRRITANT

反应信息

• 作为反应物：
  描述：

  2,2,2-trifluoro-N-(2-methoxyphenethyl)acetamide 在 硫酸 、 硝酸 作用下， 以 1,2-二氯乙烷 为溶剂， 反应 1.33h， 以93%的产率得到N-(2-methoxy-3,5-dinitrophenethyl)-2,2,2-trifluoroacetamide
  参考文献：
  名称：

  Preparation of Photoactivable Amino Acid Derivatives

  摘要：

  A range of N-protected-alpha-amino acyl-5,7-dinitroindolines 3a-z were prepared in good yields from commercially available N-protected-alpha-amino acids 1a-z by a two-step sequence of acylation and intramolecular amide N-arylation. Subsequent photochemical acylation of the N-protected-alpha-amino acyl-5,7-dinitroindolines 3e,g,r afforded the corresponding N-protected-alpha-amino acid amides 22e,g,r (77-92%) under mild conditions. All these reactions occurred with complete retention of chirality as evidenced by NMR analysis. This scheme provides an attractive and alternative method to the conventional acylation of alpha-amino acids, especially in cases where the amide bond needs to be formed without the use of a coupling reagent.

  DOI：

  10.1021/jo900442p
• 作为产物：
  描述：

  三氟乙酸酐 、 2-甲氧基苯乙胺 以 二氯甲烷 为溶剂， 反应 2.0h， 以97%的产率得到2,2,2-trifluoro-N-(2-methoxyphenethyl)acetamide
  参考文献：
  名称：

  Preparation of Photoactivable Amino Acid Derivatives

  摘要：

  A range of N-protected-alpha-amino acyl-5,7-dinitroindolines 3a-z were prepared in good yields from commercially available N-protected-alpha-amino acids 1a-z by a two-step sequence of acylation and intramolecular amide N-arylation. Subsequent photochemical acylation of the N-protected-alpha-amino acyl-5,7-dinitroindolines 3e,g,r afforded the corresponding N-protected-alpha-amino acid amides 22e,g,r (77-92%) under mild conditions. All these reactions occurred with complete retention of chirality as evidenced by NMR analysis. This scheme provides an attractive and alternative method to the conventional acylation of alpha-amino acids, especially in cases where the amide bond needs to be formed without the use of a coupling reagent.

  DOI：

  10.1021/jo900442p

文献信息

• <i>meta</i> -Selective C−H Borylation of Benzylamine-, Phenethylamine-, and Phenylpropylamine-Derived Amides Enabled by a Single Anionic Ligand
  作者：Holly J. Davis、Georgi R. Genov、Robert J. Phipps

  DOI：10.1002/anie.201708967

  日期：2017.10.16

  Clever positioning: A bipyridine ligand incorporating a remote anionic sulfonate group directs iridium-catalyzed borylation to the meta-position on a range of amide-containing arenes. It is proposed that this selectivity is a result of a hydrogen bonding interaction to correctly position the iridium metal centre in the crucial C−H activation.

  巧妙的定位：结合有远端阴离子磺酸盐基团的联吡啶配体可将铱催化的硼化反应引导至一系列含酰胺芳烃的间位。提出该选择性是氢键相互作用的结果，该氢键相互作用将铱金属中心正确定位在关键的CH活化中。
• [EN] 7-ARYL-3,9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES<br/>[FR] DERIVES DE 7-ARYL-3,9-DIAZABICYCLO(3.3.1)NON-6-ENE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE RENINE DANS LE TRAITEMENT DE L'HYPERTENSION, DE MALADIES CARDIOVASCULAIRES OU RENALES
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2003093267A1

  公开（公告）日：2003-11-13

  The invention relates to novel 3,9-diazabicyclo[3.3.1]nonene derivatives of formula (I) and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors or renin.

  该发明涉及新型3,9-二氮杂双环[3.3.1]壬烯衍生物（I）及相关化合物，以及它们作为药物组合物中活性成分的用途。该发明还涉及相关方面，包括制备这些化合物的过程、含有这些化合物中的一个或多个的药物组合物，尤其是它们作为肾素抑制剂的用途。
• 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension,cardiovascular or renal diseases
  申请人：Bezencon Olivier

  公开号：US20050176700A1

  公开（公告）日：2005-08-11

  The invention relates to novel 3,9-diazabicyclo[3.3.1]nonene derivatives of formula (I) and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors or renin.

  本发明涉及式(I)的新型3,9-二氮杂双环[3.3.1]壬烯衍生物及其相关化合物，以及它们作为药物组分在制备药物组合物中的应用。本发明还涉及相关方面，包括制备这些化合物的过程、含有其中一个或多个这些化合物的药物组合物，尤其是它们作为肾素抑制剂的应用。
• 7-ARYL-3, 9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES
  申请人：BEZENCON OLIVIER

  公开号：US20080312242A1

  公开（公告）日：2008-12-18

  The invention relates to novel 3,9-diazabicyclo[3.3.1]nonene derivatives of formula (I) and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors or renin.

  本发明涉及新型的3,9-二氮杂双环[3.3.1]壬烯衍生物，其化学式为（I），以及相关化合物，以其作为药物成分制备制药组合物。本发明还涉及相关方面，包括制备该化合物的过程，含有其中一种或多种化合物的制药组合物，尤其是其作为肾素抑制剂的用途。
• 7-ARYL-3,9-DIAZABICYCLO[3.3.1]NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES
  申请人：Actelion Pharmaceuticals Ltd.

  公开号：EP1501830A1

  公开（公告）日：2005-02-02